These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 22193214)
1. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Conaghan PG Rheumatol Int; 2012 Jun; 32(6):1491-502. PubMed ID: 22193214 [TBL] [Abstract][Full Text] [Related]
2. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Moodley I Cardiovasc J Afr; 2008; 19(2):102-7. PubMed ID: 18516356 [TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs]. Lange H; Eberhart L Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262 [TBL] [Abstract][Full Text] [Related]
5. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. McGettigan P; Henry D PLoS Med; 2013; 10(2):e1001388. PubMed ID: 23424288 [TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs]. van den Bemt BJ; Benraad HB; Rasker JJ Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414 [TBL] [Abstract][Full Text] [Related]
7. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Scheiman JM; Fendrick AM Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078 [TBL] [Abstract][Full Text] [Related]
8. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study. Johnell K; Fastbom J Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011 [TBL] [Abstract][Full Text] [Related]
13. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study. Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490 [TBL] [Abstract][Full Text] [Related]
14. Non-Steroidal anti inflammatory drugs usage in orthopaedics and trauma practice. A guide and review. Eyichukwu GO Niger J Med; 2010; 19(4):374-81. PubMed ID: 21526623 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470 [TBL] [Abstract][Full Text] [Related]